Zentek (CVE:ZEN) Shares Up 16.3% – Still a Buy?

Zentek Ltd. (CVE:ZENGet Free Report) shares were up 16.3% during trading on Thursday . The company traded as high as C$1.70 and last traded at C$1.57. Approximately 121,831 shares traded hands during mid-day trading, an increase of 271% from the average daily volume of 32,804 shares. The stock had previously closed at C$1.35.

Zentek Stock Up 3.0 %

The stock has a market cap of C$173.62 million, a PE ratio of -15.95 and a beta of 0.77. The business has a 50 day moving average price of C$1.49 and a 200 day moving average price of C$1.33. The company has a quick ratio of 7.59, a current ratio of 2.06 and a debt-to-equity ratio of 4.97.

Zentek Company Profile

(Get Free Report)

Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds.

Featured Articles

Receive News & Ratings for Zentek Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zentek and related companies with MarketBeat.com's FREE daily email newsletter.